VALUES FIRST ADVISORS, INC. – Alnylam Pharmaceuticals, Inc. Transaction History
VALUES FIRST ADVISORS, INC. portfolio value:
$1.25M
portfolio value
VALUES FIRST ADVISORS, INC. quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.31% | 201 shares | 369K | $200.16 | 6.26K |
| Q2 2022 | share | Decrease | -6.62% | -430 shares | -176K | $145.85 | 6.06K |
| Q1 2022 | share | Increase | +5.64% | 347 shares | 18K | $163.29 | 6.49K |
| Q4 2021 | share | Increase | 0.00% | 6.14K shares | 1.04M | $171.03 | 6.14K |